Xtant Medical Stock Forecast, Price & News

Xtant Medical (NYSEAMERICAN:XTNT) Frequently Asked Questions

Are investors shorting Xtant Medical?

Xtant Medical saw a decline in short interest in November. As of November 15th, there was short interest totaling 197,600 shares, a decline of 21.7% from the October 31st total of 252,500 shares. Based on an average trading volume of 140,900 shares, the days-to-cover ratio is presently 1.4 days. Currently, 1.9% of the company's stock are short sold.
View Xtant Medical's Short Interest.

When is Xtant Medical's next earnings date?

Xtant Medical is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for Xtant Medical.

How were Xtant Medical's earnings last quarter?

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) released its earnings results on Friday, November, 12th. The medical device company reported ($0.02) earnings per share (EPS) for the quarter. The medical device company earned $13.78 million during the quarter. Xtant Medical had a negative trailing twelve-month return on equity of 11.44% and a negative net margin of 5.92%.
View Xtant Medical's earnings history.

When did Xtant Medical's stock split? How did Xtant Medical's stock split work?

Xtant Medical shares reverse split on Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 13th 2018. An investor that had 100 shares of Xtant Medical stock prior to the reverse split would have 8 shares after the split.

Who are Xtant Medical's key executives?

Xtant Medical's management team includes the following people:

• Sean E. Browne, President, Chief Executive Officer & Director
• Gregory P. Jensen, Chief Financial Officer & Vice President-Finance
• Kevin D. Brandt, Chief Commercial Officer & Senior Vice President
• Stephen C. Smith, VP-Regulatory Affairs & Quality Assurance

Who are some of Xtant Medical's key competitors?

Some companies that are related to Xtant Medical include aTyr Pharma (LIFE), MiNK Therapeutics (INKT), Black Diamond Therapeutics (BDTX), Cardiff Oncology (CRDF), Fusion Pharmaceuticals (FUSN), INmune Bio (INMB), Harpoon Therapeutics (HARP), Eiger BioPharmaceuticals (EIGR), Solid Biosciences (SLDB), TCR2 Therapeutics (TCRR), Achilles Therapeutics (ACHL), Aptose Biosciences (APTO), Cognition Therapeutics (CGTX), Adverum Biotechnologies (ADVM) and AVROBIO (AVRO).
View all of XTNT's competitors.

What other stocks do shareholders of Xtant Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Xtant Medical investors own include Aurinia Pharmaceuticals (AUPH), CytRx (CYTR), Protalix BioTherapeutics (PLX), Heat Biologics (HTBX), Neovasc (NVCN), Rexahn Pharmaceuticals (REXN), Biopharmx (BPMX), Adamis Pharmaceuticals (ADMP), Lipocine (LPCN) and Synergy Pharmaceuticals (SGYP).

What is Xtant Medical's stock symbol?

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

Who are Xtant Medical's major shareholders?

Xtant Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Altium Capital Management LP (7.21%) and Renaissance Technologies LLC (0.79%).
View institutional ownership trends for Xtant Medical.

Which major investors are selling Xtant Medical stock?

XTNT stock was sold by a variety of institutional investors in the last quarter, including Altium Capital Management LP, and Renaissance Technologies LLC.
View insider buying and selling activity for Xtant Medical or view top insider-selling stocks.

How do I buy shares of Xtant Medical?

Shares of XTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Xtant Medical's stock price today?

One share of XTNT stock can currently be purchased for approximately $0.72.

How much money does Xtant Medical make?

Xtant Medical has a market capitalization of $62.43 million and generates $53.34 million in revenue each year. The medical device company earns $-7.02 million in net income (profit) each year or ($0.04) on an earnings per share basis.

How many employees does Xtant Medical have?

Xtant Medical employs 110 workers across the globe.

What is Xtant Medical's official website?

The official website for Xtant Medical is xtantmedical.com.

Where are Xtant Medical's headquarters?

Xtant Medical is headquartered at 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States.

How can I contact Xtant Medical?

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The medical device company can be reached via phone at (406) 388-0480, via email at [email protected], or via fax at 406-388-1354.